Back to results
US 2012/0232129 A1Published application
Multiantivirus compound, composition and method for treatment of virus diseases
AssigneeBiocell Laboratories
InventorZenoviy Tkachuk
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeBiocell Laboratories
InventorZenoviy Tkachuk
Estimating the term…
A method for obtaining a new antiviral compound with multiple action against many viruses, comprising modified highly purified yeast RNA, a pharmaceutical composition comprising such RNA, and a method for the treatment and prevention of viral disease comprising administering to a patient a composition comprising an amount effective to ameliorate the symptoms of viral disease of ribonucleic acid. The exogenous modified yeast RNA has a pronounced multiple anti-virus action in a wide range of concentrations. The modified yeast RNA is capable of inhibiting the reproduction of viruses from Orthomyxoviridae, Paramyxovirus, Hepatitis, Herpesviridae families, enterovirus and adenovirus. Also, the modified yeast RNA is capable of inhibiting the reproduction of influenza viruses, hepatitis C virus, genital herpes, human immunodeficiency virus and Coxsackie B virus.
A method of preventing or treating an infection by a virus in a patient, comprising administering to the patient a composition comprising a purified RNA extract combined with a sugar in an amount effective to prevent or treat the infection.
A composition for preventing or treating an infection by a virus, comprising a purified RNA extract combined with a sugar.
A method of preparing a composition for preventing or treating an infection by a virus, comprising heating a purified yeast RNA extract with at least one sugar to a temperature in the range 40-70° C.
Dependencies are inferred from the claim text.